Sens Id
1 known investors
SensID produces clinical genomics reference materials and quality controls, including gDNA, cfDNA/ctDNA, plasma, and FFPE samples of human origin with defined genetic modifications, along with DNA-free negative controls for liquid biopsy. These products are used by molecular diagnostics developers and labs for validating diagnostic tests, calibrating instruments (NGS, PCR), quality monitoring, and accreditation.
BiotechHealthtechMedical Devices